Characteristics | Training cohort | Â | Validation cohort | Â | ||
---|---|---|---|---|---|---|
 | DON | TAO without DON | p value | DON | TAO without DON | p value |
Age (years) | 50.93 ± 8.39 | 45.9 ± 8.64 |  < 0.001 | 52.57 ± 12.17 | 47.1 ± 9.0 | 0.039 |
Patients (n) | 46 | 42 | Â | 13 | 27 | Â |
Orbits (n) | 83 | 80 | Â | 21 | 51 | Â |
Sex (M/F) | 25/21 | 19/23 | 0.522 | 7/6 | 18/9 | 0.439 |
Euthyroid TAO (n) | 5 | 3 | Â | 2 | 2 | Â |
Smoker (n) | 18 | 15 | 0.818 | 5 | 9 | 0.785 |
Duration of TAO | 5.59 ± 3.77 | 8.93 ± 10.9 |  < 0.001 | 6.29 ± 4.33 | 6.97 ± 4.9 | 0.58 |
VA | 0.6 (0.5, 1.0) | 0.85 (0.8, 1.0) |  < 0.001 | 0.5(0.25, 0.8) | 0.8 (0.8, 1.0) |  < 0.001 |
CAS | 4 (2, 5) | 2 (1, 2.75) |  < 0.001 | 3 (2, 3) | 2 (1.5, 2) | 0.002 |
Proptosis (mm) | 19 (18, 21) | 19 (17.25, 20) | 0.058 | 19 (18, 20) | 19 (18, 20) | 0.157 |
MI (%) | 62.66 ± 9.04 | 58.98 ± 10.68 | 0.019 | 70.02 ± 9.54 | 60.67 ± 9.64 |  < 0.001 |
Apical crowding sign (n) | 56 | 19 |  < 0.001 | 14 | 13 | 0.002 |
Stretching sign (n) | 54 | 17 |  < 0.001 | 13 | 12 | 0.003 |